Masaaki Takeshita
Gunma University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Masaaki Takeshita.
Biotherapy | 1992
Masaaki Takeshita; Seiji Nakamura; Fujio Makita; Susumu Ohwada; Yukio Miyamoto; Yasuo Morishita
We examined whether orally administered RBS (rice bran saccharide), prepared from rice bran by hot water extraction, increases immunocompetence, inhibits gastrointestinal carcinogenesis with N-ethyl-N′-nitro-N-nitrosoguanidine (ENNG) or shows an antitumor effect. After the administration of RBS, phytohemagglutinin (PHA)- and pokeweed mitogen (PWM)-stimulated blastogenesis of lymphocytes derived from the mesenteric lymph nodes and peripheral blood was enhanced, and the helper/ suppressor T-cell ratio was elevated, and migration activity of peritoneal macrophages was also increased in rats treated continuously with ENNG. ENNG-induced gastrointestinal carcinomas were observed in 43% of those administered RBS (ENNG-RBS) as compared with 88% in the control (ENNG) and 94% in the prednisolone (PRD) group (ENNG-PRD). The 12-month survival rate of rats bearing gastrointestinal cancer was 58% in the ENNG-RBS group as compared with 25% in the ENNG group and 15% in the ENNG-PRD group. RBS prevented the reduction in immunocompetence in the course of carcinogenesis, suppressed carcinogenesis, and prolonged the survival of rats with gastrointestinal cancer. Antitumor activities of RBS are thought to be a kind of host mediated action. The growth inhibition ratio of transplantable ENNG-induced cancer in Wistar rats was 42.1% in the RBS and 51.8% in the 5-FU group. Since little is known about the potent antitumor activity of α-glucan, it would be interesting to consider the relationship between the structure and the biological activities of polysaccharides.
Surgery Today | 1990
Masaaki Takeshita; Fujio Makita; Izumi Takeyoshi; Hitoshi Ishikawa; Seiji Nakamura; Susumu Owada; Yukio Miyamoto; Masaru Izuo; Satonori Kurashige
We examined whether the Streptococcal preparation OK-432, an immunopotentiating agent, increases immunocompetence of the gut-associated lymphoid system (GALS), inhibits gastrointestinal carcinogenesis, and has an anti-tumor effect.14C-labelled OK-432 was orally and intraperitoneally administered to rats, and the distribution of the agent in various organs then serially evaluated. The concentration of OK-432 in Peyers patches and mesenteric lymph nodes was higher after oral administration than after intraperitoneal administration, and showed a biphasic pattern peaking at 30 minutes and 5 hours following administration, in the Peyers patches. With regard to immunocompetence, PHA- and PWM-stimulated blastogenesis of lymphocytes derived from the mesenteric lymph nodes and peripheral blood enhanced, and the helper/suppressor T-cell ratio was elevated after the oral administration of OK-432. Moreover, chemotactic activity of peritoneal macrophages was also increased. ENNG-induced gastrointestinal carcinogenesis was observed in 60 per cent of the rats orally administered OK-432 as compared with 88 per cent of the controls. The 13-month survival rate of the rats with gastrointestinal cancer was 50 per cent in those administered OK-432 as compared with 25 per cent in those administered OK-432 as compared with 25 per cent in the controls. When administered orally, the agent prevented reduction in immunocompetence in the course of carcinogenesis, suppressed carcinogenesis, and prolonged the survival of animals with cancer without any of the side effects associated with injection. The oral administration of OK-432 is thus considered to be an effective non-specific immunotherapy against gastrointestinal malignancies.
The Kitakanto Medical Journal | 2003
Takashi Yoshida; Takao Yokoe; Masaaki Takeshita; Jun Horiguchi; Yukio Koibuchi; Takayuki Kanou; Kotaro Iijima; Miho Yoshida; Mami Kikuchi; Daisuke Takata; Yuichi Iino; Yasuo Morishita
Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi | 1990
Izumi Takeyoshi; Tomohiro Inoue; Susumu Ohwada; Masaaki Takeshita; Yukio Miyamoto; Tadakazu Kawai; Masaru Izuo
Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi | 1989
Yukio Miyamoto; Masaaki Takeshita; Susumu Ohwada; Tadasazu Kawai; Osamu Utida; Masaru Izuo
Nihon Rinsho Geka Gakkai Zasshi (journal of Japan Surgical Association) | 1992
Fujio Makita; Yukio Miyamoto; Masaaki Takeshita; Susumu Owada; Izumi Takeyoshi; Masaru Izumi; Sinichi Kakinuma; Yasuo Morishita
The Kitakanto Medical Journal | 1991
Fujio Makita; Masaaki Takeshita; Susumu Owada; Seiji Nakamura; Izumi Takeyoshi; Yukio Miyamoto; Yasuo Morishita
The Kitakanto Medical Journal | 1991
Masaaki Takeshita; Tooru Watanabe; Tamotsu Yamada; Isao Kobayashi; Seiji Nakamura; Hitoshi Ishikawa; Masaru Izumi; Yoshifumi Tanahashi; Susumu Owada; Yukio Miyamoto
The Kitakanto Medical Journal | 1990
Yukio Miyamoto; Masaaki Takeshita; Susumu Ohwada
The Kitakanto Medical Journal | 1990
Yukio Miyamoto; Masaaki Takeshita; Susumu Ohwada; Izumi Takeyoshi; Masaru Izumi